Henning Mouridsen, MD, PhD

Managing endocrine-responsive breast cancer: Have all the necessary questions been asked to guide us forward?

Henning Mouridsen, MD, PhD

Copenhagen University Hospital
Copenhagen, Denmark

Michael Gnant, MD

Reassessing adjuvant systemic therapy for early breast cancer

Michael Gnant, MD

Medical University of Vienna
Vienna, Austria

Julie Gralow, MD

Anthracyclines as a component of adjuvant chemotherapy: For which patients is this necessary and appropriate?

Julie Gralow, MD

University of Washington School of Medicine
Seattle, Washington

Angelo Di Leo, MD, PhD

Novel Strategies for the management of disease progression following standard chemotherapy

Angelo Di Leo, MD, PhD

Hospital of Prato, Istituto Toscano Tumori
Prato, Italy

Joseph Gligorov, MD

HER2-amplified breast cancer: Refining our approach to acheive clinical outcomes

Joseph Gligorov, MD

Tenon Hospital
Paris, France